Skip to main content
FDA Shortage Check

Is Marplan (Isocarboxazid Tablet) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Marplan: in shortage (FDA, Oct 24)

Tablets
A generic tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Lifsa Drugs LLC, Aug 6, 2026
DRUG
Marplan
FDA LISTING
FORM
tablets
STATUS
Currently in Shortage
FIRST POSTED
Apr 16, 2026
LAST FDA UPDATE
Aug 6, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 1 presentation: 0 unavailable · 1 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Isocarboxazid Tablet. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Lifsa Drugs LLC1 presentation · 1 limited

Contact (FDA's listing): 833.627.0070

  • 10 mg, 100 count bottle

    Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01)

    Estimated recovery: TBD

    NDC 72336-032-01Revised

    Limited Availability

What the manufacturers told FDA

  • Lifsa Drugs LLC · ‘Estimated recovery: TBD’ · updated Aug 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Marplan in shortage?
Yes. As of Oct 24, 2026, FDA lists Isocarboxazid Tablet as currently in shortage: 1 presentations, 0 unavailable and 1 limited.
When will the Marplan shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Marplan?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.